...
首页> 外文期刊>癌と化学療法 >An outpatient with unresectable pancreatic cancer treated with gemcitabine showing prolonged NC (22 months)
【24h】

An outpatient with unresectable pancreatic cancer treated with gemcitabine showing prolonged NC (22 months)

机译:吉西他滨治疗的无法切除的胰腺癌门诊患者,其NC延长(22个月)

获取原文
获取原文并翻译 | 示例

摘要

A 76-year-old man developed jaundice and was hospitalized in January 2002. A 3 cm tumor was found in the head of the pancreas by abdominal CT, and the patient underwent laparotomy. The tumor was histologically diagnosed as a well-differentiated adenocarcinoma, and showed extensive invasion to the portal vein (T4NXM 0 Stage IV a). Incisional biopsy and hepaticojejunostomy were performed. On the basis of a drug sensitivity test, chemotherapy with 800 mg/m2/week gemcitabine was administered. The patient showed prolonged NC without any symptoms for 22 months, although the CEA and DUPAN-2 levels gradually increased during this time and massive ascites were detected in a routine abdominal CT at 22 months postsurgery. The patient died after 25 months of chemotherapy. Here we report a case of unresectable pancreatic cancer treated with gemcitabine on the basis of a drug sensitivity test.
机译:一名76岁的男子患了黄疸病,并于2002年1月住院。腹部CT检查发现胰腺头部3厘米长,患者接受了剖腹手术。在组织学上,该肿瘤被诊断为高度分化的腺癌,并显示出对门静脉的广泛侵袭(T4NXM 0 IV期a)。进行切口活检和肝空肠造口术。根据药物敏感性测试,以800 mg / m2 /周的吉西他滨进行化疗。尽管在此期间CEA和DUPAN-2的水平逐渐升高,并且在术后22个月的常规腹部CT中检测到大量腹水,但患者的NC症状延长了22个月,但没有任何症状。患者在化疗25个月后死亡。在这里,我们根据药物敏感性测试报告了吉西他滨治疗无法切除的胰腺癌的情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号